LP

Laurent POIROT

CE Cellectis: 36 patents #2 of 71Top 3%
AT Allogene Therapeutics: 1 patents #11 of 37Top 30%
Overall (All Time): #91,517 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 25 most recent of 36 patents

Patent #TitleCo-InventorsDate
12391933 Targeted gene insertion for improved immune cells therapy Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Julien Valton 2025-08-19
12365733 Method for improving production of car T cells Alex BOYNE, Philippe Duchateau, Alexandre Juillerat 2025-07-22
12252699 Method for generating t-cells compatible for allogenic transplantation David Sourdive, Philippe Duchateau, Jean-Pierre Cabaniols 2025-03-18
12221478 Targeted gene integration of CRS inhibitor genes for improved immune cells therapy Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Julien Valton, Mohit Sachdeva 2025-02-11
12209125 Targeted gene integration of NK inhibitors genes for improved immune cells therapy Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Julien Valton 2025-01-28
12171820 Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment Mathieu SIMON 2024-12-24
12144825 Cellular immunotherapy for repetitive administration David Sourdive, Aymeric Duclert, Mathieu SIMON, Philippe Duchateau, Alan Marc WILLIAMS 2024-11-19
11959091 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Philippe Duchateau, Andre Choulika 2024-04-16
11903968 Engineered immune cells resistant to tumor microenvironment Philippe Duchateau, Anne-Sophie GAUTRON, Julien Valton 2024-02-20
11891614 Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2024-02-06
11873511 Targeted gene insertion for improved immune cells therapy Brian BUSSER, Philippe Duchateau, Alexandre Juillerat, Julien Valton 2024-01-16
11820996 Method for generating T-cells compatible for allogenic transplantation David Sourdive, Philippe Duchateau, Jean-Pierre Cabaniols 2023-11-21
11692169 Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells Philippe Duchateau 2023-07-04
11603539 Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2023-03-14
11414674 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2022-08-16
11365430 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Philippe Duchateau, Andre Choulika 2022-06-21
11311575 Methods for engineering highly active T cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cécile SCHIFFER-MANNIOUI, Andrew M. Scharenberg +1 more 2022-04-26
11304975 Methods for engineering allogeneic and highly active t cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cécile SCHIFFER-MANNIOUI, Andrew M. Scharenberg +1 more 2022-04-19
11274316 Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells Roman Galetto, Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Andrew M. Scharenberg +1 more 2022-03-15
11186824 Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients Philippe Duchateau, Jean-Pierre Cabaniols, Julien Valton 2021-11-30
11072644 Inhibitory chimeric antigen receptors Arvind Rajpal, Shobha Potluri, Alexandre Juillerat, Thomas Charles PERTEL, Donna Marie Stone +1 more 2021-07-27
10988542 Chimeric antigen receptors with integrated controllable functions Alexandre Juillerat, Philippe Duchateau 2021-04-27
10894093 Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation Julien Valton, Veronique Zennou, Philippe Duchateau 2021-01-19
10870864 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system Philippe Duchateau, Andre Choulika 2020-12-22
10836998 Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells Philippe Duchateau 2020-11-17